While the COVID-19 pandemic forced its way into every aspect of our lives for the past 18 months, it is not the only major ongoing health crisis. The opioid epidemic is still a real threat to our population despite being somewhat overshadowed in the …
2020 is a year like no other. The coronavirus pandemic has magnified the significance of public health. Social distancing, masks, plexiglass barriers, hand sanitizer and contactless pickups have become parts of our everyday lives, and the importance…
An important judgement on opioids in Oklahoma While the country is still experiencing the devastating impact of a full-fledged opioid epidemic in 2019, the day may have arrived for a select group of drug manufacturers to face court-mandated restitut…
Like many others that have come before it, this is an article about how we can combat the opioid epidemic. But if the educational tips here help even one person think more carefully about opioid alternatives, it has accomplished what it set out to do…
In late 2011, a team of claims management and managed care leaders at Sedgwick met to identify how they could address the troubling rise in opioid prescriptions and morphine equivalent dosage (MED). What followed was the development of a team…
Claims administrators have an invaluable opportunity to help future pharmacists understand the challenges regarding prescription drug use for occupational injuries. A pharmacist intern program, like the one we offer at Sedgwick, can provide ex…
Fostering awareness in the complex world of prescription drugs It is vital for a claims administrator to have pharmacists on staff because the current reality in workers’ compensation injury care is that prescription drug activity is a dangerous and…
The 2017 National Prescription Drug Take-Back Day is Saturday, April 29 from 10:00 a.m. – 2:00 p.m. The day was established in 2010 by the U.S. Drug Enforcement Administration (DEA) to help reduce prescription drug risks and promote safety. Accord…
State governments are responding to the opioid epidemic. Recently, the New Jersey governor signed new legislation that limits prescribers’ capacity to provide first-time opioid prescriptions for more than five days. The New Jersey state senate passed…
At Sedgwick, we are committed to steering people away from opioid addiction and finding solutions to returning them back to healthy, productive lives. However, the lure of such drugs can begin even before entering the workforce and experiencing an …
Risk managers should always be aware of injured worker opioid use across their open claims and make sure that there is persistent clinician involvement with prescribers. I am a complex pharmacy management nurse for Sedgwick. I want to share one of…
Gabapentin is approved by the Food and Drug Administration for the management of post-herpetic neuralgia, pain associated with shingles, in adults and is used adjunctively in the treatment of partial onset seizures in adults and children. The …
Participate in National Prescription Drug Take-Back Day today, Saturday, April 30 from 10:00 a.m. – 2:00 p.m. and you could save a life. National Prescription Drug Take-Back Day was established in 2010 by the Drug Enforcement Administration (DEA) …
It was my privilege to present along with Dr. Paul Peak of Sedgwick at the 2016 National RX Drug and Heroin Summit in Atlanta, Georgia to discuss dangerous prescribing practices and at-risk patients. The conference was highlighted by a public ap…
Last year, Dr. Reema Hammoud of Sedgwick shared a blog regarding National Prescription Drug Take-Back Day. The next National Prescription Drug Take-Back Day, sponsored by the U.S. Drug Enforcement Administration (DEA), will be held April 30, 2016. Ho…